v3.19.3
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net loss $ (4,437,326) $ (1,462,467)
Adjustments to reconcile net loss to net cash used in operations    
Non-cash interest expense 1,263,745 1,222,556
Amortization and depreciation 61,258 7,626
Loss (Gain) on fair value change of derivatives 453,770 (235,194)
Loss (Gain) on extinguishment of debt 797,996 (425,595)
Stock compensation expense 824,416 42,083
Issuance of convertible notes for fees 9,500
Impairment of intangible asset 44,200
Changes in operating assets and liabilities:    
Inventory 1,625 19,734
Accounts receivable 8,593 (32,092)
Prepaid assets 7,839 21,797
Accounts payable and accrued expenses 226,688 133,400
Accounts payable and accrued expenses, related parties (839) 224,736
Net cash used in operating activities (748,035) (473,916)
Cash flows from investing activities:    
Payment of license fees (200,000)
Cash acquired in acquisitions 21,580
Purchase of office and computer equipment (4,941)
Payments for extensions of patents (13,400)
Net cash provided by (used in) investing activities (200,000) 3,239
Cash flows from financing activities:    
Redemption of common stock (350,000)
Proceeds from sale of common stock 100,000 250,000
Proceeds from issuances of convertible notes payable 890,450 730,000
Proceeds from issuances of notes payable 15,000 200,000
Payments of principal of convertible note payable and notes payable (107,113) (386,846)
Net cash provided by financing activities 898,337 443,154
Effects of exchange rate on cash and cash equivalents 11 (4,157)
Net decrease in cash (49,687) (31,680)
Cash, Beginning of period 50,903 110,792
Cash, End of period 1,216 79,112
Supplemental disclosure of cash flow information:    
Cash paid for interest 65,656 36,596
Cash paid for income taxes
Schedule of non-cash Investing or Financing Activity:    
Original issue discount included in notes payable 119,875 186,425
Issuance of common stock upon convertible note and accrued interest conversion 324,584 589,176
Acquisition of Spinal Resources, Inc.    
Acquisitions    
Cash paid 200,000
Issuance of Common stock as consideration 49,000
Assumed liabilities 524,387
Issuance of note as consideration 768,844
Common stock to be issued 245,000
License fee payable 1,234,089
Present value of option to buy SRI 2,834,692
Inventory (389,634)
Fixed Assets (379,210)
Patent rights (2,810,000)
Goodwill (2,277,168)
Cash acquired
Acquisition of Spinus, LLC    
Acquisitions    
Issuance of Common stock as consideration 250,000
Assumed liabilities 278,779
Accounts receivable (19,054)
Other Assets (250,000)
Tradename (44,200)
Goodwill (194,951)
Cash acquired 20,574
Acquisition of Newmarkt    
Acquisitions    
Issuance of Common stock as consideration 2,798
Assumed liabilities 62,464
Paid in capital (53,990)
Inventory (8,359)
Prepaid expenses (1,907)
Cash acquired $ 1,006

Source